Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Prostate Cancer

Free Subscription 08.07.2024 1 AJR Am J Roentgenol 1 Am J Clin Pathol 1 BJU Int 1 BMC Cancer 4 BMC Urol 1 Br J Cancer 2 Cancer 2 Cancer Imaging 1 Cancer Lett 1 Cancer Res 1 Clin Cancer Res 1 Eur Radiol 1 Int J Urol 3 J Nucl Med 1 J Urol 2 PLoS One 1 Proc Natl Acad Sci U S A 2 Prostate

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJR Am J Roentgenol

1. THAMPY R, Spilseth B
   Beyond the AJR: Increased Use of Prostate MRI Before Biopsy Reduces Biopsy Frequency Without Compromising Detection of Aggressive Cancer.
   AJR Am J Roentgenol. 2023 Oct 25. doi: 10.2214/AJR.23.30407.
   PubMed        
   
   

   
   Am J Clin Pathol

2. KRYVENKO ON, Epstein JI, Merhe A, Iakymenko OA, et al
   Radical prostatectomy cancer grade and percentage of Gleason pattern 4 estimated by global vs individual tumor grading correlate differently with the risk of biochemical recurrence in Grade Group 2 and 3 cancers.
   Am J Clin Pathol. 2024;162:51-61.
   PubMed         Abstract available
   
   

   
   BJU Int

3. ARVIDSSON I, Svanemur E, Marginean F, Simoulis A, et al
   Artificial intelligence for detection of prostate cancer in biopsies during active surveillance.
   BJU Int. 2024 Jul 4. doi: 10.1111/bju.16456.
   PubMed         Abstract available
   
   

   
   BMC Cancer

4. KIM JS, Taaffe DR, Galvao DA, Clay TD, et al
   Enhancing circulatory myokines and extracellular vesicle uptake with targeted exercise in patients with prostate cancer (the MYEX trial): a single-group crossover study.
   BMC Cancer. 2024;24:784.
   PubMed         Abstract available
   
   

   
   BMC Urol

5. OH C, O'Callaghan M
   Seminal Papers in Urology: Darolutamide and survival in metastatic, hormone-sensitive prostate cancer.
   BMC Urol. 2024;24:135.
   PubMed         Abstract available
   
   
6. LIAQAT M, Khan RA, Fischer F, Kamal S, et al
   Relationship between prostate-specific antigen, alkaline phosphatase levels, and time-to-tumor shrinkage: understanding the progression of prostate cancer in a longitudinal study.
   BMC Urol. 2024;24:137.
   PubMed         Abstract available
   
   
7. AJIBOYE BO, Fatoki TH, Akinola OG, Ajeigbe KO, et al
   In silico exploration of anti-prostate cancer compounds from differential expressed genes.
   BMC Urol. 2024;24:138.
   PubMed         Abstract available
   
   
8. HSIEH AR, Luo YL, Bao BY, Chou TC, et al
   Comparative analysis of genetic risk scores for predicting biochemical recurrence in prostate cancer patients after radical prostatectomy.
   BMC Urol. 2024;24:136.
   PubMed         Abstract available
   
   

   
   Br J Cancer

9. CYLL K, Skaaheim Haug E, Pradhan M, Vlatkovic L, et al
   DNA ploidy and PTEN as biomarkers for predicting aggressive disease in prostate cancer patients under active surveillance.
   Br J Cancer. 2024 Jul 3. doi: 10.1038/s41416-024-02780.
   PubMed         Abstract available
   
   

   
   Cancer

10. GONG J, Janes JL, Trustram Eve C, Stock S, et al
    Epidemiology, treatment patterns, and clinical outcomes in de novo oligometastatic hormone-sensitive prostate cancer.
    Cancer. 2024 Jul 1. doi: 10.1002/cncr.35466.
    PubMed         Abstract available
    
    
11. NIERENGARTEN MB
    Novel hormone is safe and effective in men receiving radiotherapy for prostate cancer.
    Cancer. 2024;130:2408.
    PubMed        
    
    

    
    Cancer Imaging

12. GROSS M, Eisenhuber E, Assinger P, Schima R, et al
    MRI-guided in-bore biopsy of the prostate - defining the optimal number of cores needed.
    Cancer Imaging. 2024;24:81.
    PubMed         Abstract available
    
    
13. YANG J, Xiao L, Zhou M, Li Y, et al
    [(68)Ga]Ga?PSMA?617 PET-based radiomics model to identify candidates for active surveillance amongst patients with GGG 1-2 prostate cancer at biopsy.
    Cancer Imaging. 2024;24:86.
    PubMed         Abstract available
    
    

    
    Cancer Lett

14. LIU YN, Liu MK, Wen YC, Li CH, et al
    Binding of interleukin-1 receptor antagonist to cholinergic receptor muscarinic 4 promotes immunosuppression and neuroendocrine differentiation in prostate cancer.
    Cancer Lett. 2024 Jun 28:217090. doi: 10.1016/j.canlet.2024.217090.
    PubMed         Abstract available
    
    

    
    Cancer Res

15. YOO YA, Quan S, Yang W, Guo Q, et al
    Asparagine Dependency is a Targetable Metabolic Vulnerability in TP53-Altered Castration-Resistant Prostate Cancer.
    Cancer Res. 2024 Jul 3. doi: 10.1158/0008-5472.CAN-23-2910.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

16. LENIS AT, Ravichandran V, Brown S, Alam SM, et al
    Microsatellite Instability, Tumor Mutational Burden, and Response to Immune Checkpoint Blockade in Patients with Prostate Cancer.
    Clin Cancer Res. 2024 Jul 1. doi: 10.1158/1078-0432.CCR-23-3403.
    PubMed         Abstract available
    
    

    
    Eur Radiol

17. SCHRADER A, Netzer N, Hielscher T, Gortz M, et al
    Prostate cancer risk assessment and avoidance of prostate biopsies using fully automatic deep learning in prostate MRI: comparison to PI-RADS and integration with clinical data in nomograms.
    Eur Radiol. 2024 Jul 2. doi: 10.1007/s00330-024-10818.
    PubMed         Abstract available
    
    

    
    Int J Urol

18. DI BELLO F, Fraia A, Pezone G, Colla Ruvolo C, et al
    The role of lipidic balance on erectile dysfunction in prostate cancer patients undergoing robotic surgery.
    Int J Urol. 2024 Jul 3. doi: 10.1111/iju.15516.
    PubMed         Abstract available
    
    

    
    J Nucl Med

19. YADAV S, Jiang F, Kurkowska S, Saelee R, et al
    Assessing Response to PSMA Radiopharmaceutical Therapies with Single SPECT Imaging at 24 Hours After Injection.
    J Nucl Med. 2024 May 9:jnumed.123.267208. doi: 10.2967/jnumed.123.267208.
    PubMed         Abstract available
    
    
20. RATHKE H, Winter E, Bruchertseifer F, Rohrich M, et al
    Deescalated (225)Ac-PSMA-617 Versus (177)Lu/(225)Ac-PSMA-617 Cocktail Therapy: A Single-Center Retrospective Analysis of 233 Patients.
    J Nucl Med. 2024;65:1057-1063.
    PubMed         Abstract available
    
    
21. ELLS Z, Grogan TR, Czernin J, Dahlbom M, et al
    Dosimetry of [(177)Lu]Lu-PSMA-Targeted Radiopharmaceutical Therapies in Patients with Prostate Cancer: A Comparative Systematic Review and Metaanalysis.
    J Nucl Med. 2024 Jul 3:jnumed.124.267452. doi: 10.2967/jnumed.124.267452.
    PubMed         Abstract available
    
    

    
    J Urol

22. RIVIERE P, Deshler LN, Morgan KM, Qiao EM, et al
    PSA Stratification for Predicting Advanced Prostate Cancer Events in Men Approaching Age-Limits for Recommended Screening.
    J Urol. 2024 Jul 5:101097JU0000000000004138. doi: 10.1097/JU.0000000000004138.
    PubMed         Abstract available
    
    

    
    PLoS One

23. BUTT MA, Kaleem MF, Bilal M, Hanif MS, et al
    Using multi-label ensemble CNN classifiers to mitigate labelling inconsistencies in patch-level Gleason grading.
    PLoS One. 2024;19:e0304847.
    PubMed         Abstract available
    
    
24. BLOEMBERG J, Hoppener B, Coolen B, Sakes A, et al
    Design and evaluation of a pneumatic actuation unit for a wasp-inspired self-propelled needle.
    PLoS One. 2024;19:e0306411.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

25. ZAIDI S, Park J, Chan JM, Roudier MP, et al
    Single-cell analysis of treatment-resistant prostate cancer: Implications of cell state changes for cell surface antigen-targeted therapies.
    Proc Natl Acad Sci U S A. 2024;121:e2322203121.
    PubMed         Abstract available
    
    

    
    Prostate

26. PETERS DE, Brownlee M, Layne-Colon D, Slusher BS, et al
    Discovery of PSMA in the prostate of the common marmoset (Callithrix jacchus).
    Prostate. 2024;84:1086-1088.
    PubMed         Abstract available
    
    
27. GREENLAND NY, Cooperberg MR, Carroll PR, Cowan JE, et al
    Morphologic patterns observed in prostate biopsy cases with discrepant grade group and molecular risk classification.
    Prostate. 2024;84:1076-1085.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.